Skip to content

Exercise Capacity in Diseases and Health

Exercise Capacity in Diseases and Health

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02575469
Enrollment
500
Registered
2015-10-14
Start date
2017-10-01
Completion date
2036-01-01
Last updated
2017-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Capacity

Brief summary

Exercise capacity is a key factor to evaluate and treat patients in different diseases (e.g. ischemic heart disease, chronic obstructive pulmonary disease, cystic fibrosis). The best way to measure exercise capacity is to perform a cardiopulmonary exercise testing. Normal/reference values in health and disease relate to specific population and subpopulations. The population in Israel is unique in its diversity. Objectives: Data collection of exercise capacity assessment in health and illness in the northern of Israel for future local database. Population: 500 Patients evaluated routinely in the exercise lab (pediatric cardiology institute) and healthy volunteers evaluated as controls. Study design: Prospective observational study. Participants will answer a health related questioner, undergo a physical examination, perform a cardiopulmonary exercise test on a treadmill or a cycle ergometer.

Detailed description

Exercise capacity is a key factor to evaluate and treat patients in different diseases (e.g. ischemic heart disease, chronic obstructive pulmonary disease, cystic fibrosis). The best way to measure exercise capacity is to perform a cardiopulmonary exercise testing. Normal/reference values in health and disease relate to specific population and subpopulations. The population in Israel is unique in its diversity. Objectives: Data collection of exercise capacity assessment in health and illness in the northern of Israel for future local database. Population: 500 Patients evaluated routinely in the exercise lab (pediatric cardiology institute) and healthy volunteers evaluated as controls. Study design: Prospective observational study. Participants will answer a health related questioner, undergo a physical examination, perform a cardiopulmonary exercise test on a treadmill or a cycle ergometer .

Interventions

None listed

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Ability to complete full exercise evaluation (including cardiopulmonary exercise testing).

Exclusion criteria

* Acute illness on visit day. * for healthy volunteers: chronic disease or use of medications. * Professional athletes.

Design outcomes

Primary

MeasureTime frame
VO2 (oxygen consumption)30 minutes

Countries

Israel

Contacts

Primary ContactAbraham Lorber, MD
a_lorber@rambam.health.gov.il+972-4-7774630
Backup ContactRonen Bar-Yoseph, MD
ronenfabi@gmail.com+972-4-777-4304

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026